Alta Wealth Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
CI
FCBT
MCM
Alta Wealth Advisors's XPH Position: Q2 2023 in Review
Alta Wealth Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2023, closing a stake of 7,070 shares — an estimated $290K sold.
Alta Wealth Advisors first reported a position in XPH in Q4 2022 and held it in 2 quarters. The position peaked at $290K in Q1 2023. 59 funds tracked by Wall St. Rank hold XPH as of Q2 2023.
- Alta Wealth Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
- Alta Wealth Advisors sold 7,070 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2023, an estimated $290K.
- Alta Wealth Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2022 and held it in 2 quarters.
- Alta Wealth Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $290K in Q1 2023.
- 59 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2023.
Based on Alta Wealth Advisors's 13F filing for Q2 2023, filed 17 Jul 2023.